
Sign up to save your podcasts
Or


In this week's episode, written by guest writer Daniel Benton, we explore the Hawthorne Effect. This the phenomenon that people tend to do better in research studies just by being observed. We look into what this effect is, how it works, and how it makes clinical research trials beneficial to every participants simply by being observed.
References:
Sommer R. The Hawthorne dogma. Psychological Bulletin [Internet]. 1968 Dec 1 [cited 2026 July 21];70(6, Pt.1):592–5. Available from: https://www.researchgate.net/publication/232457651_the_hawthorne_dogma
Mayo E. The Human Problems of an Industrial Civilization. Nature. 1933 Aug;134(3380):201–1.
Menezes P. Trial effect: the road from efficacy to effectiveness. Clinical Investigation [Internet]. 2012 May [cited 2026 July 21];2(5):443–5. Available from: https://www.ovid.com/journals/clni/abstract/10.4155/cli.12.34~trial-effect-the-road-from-efficacy-to-effectiveness
Brody T. Chapter 7 - Placebo Arm as Part of Clinical Trial Design. In: Clinical Trials (Second Edition) [Internet]. Second Edition. Boston: Academic Press; 2016. p. 155–72. Available from: https://www.sciencedirect.com/science/article/pii/B9780128042175000072
Hróbjartsson A, Gøtzsche PC. Is the Placebo Powerless? New England Journal of Medicine [Internet]. 2001 May 24 [cited 2026 July 21];344(21):1594–602. Available from: https://www.nejm.org/doi/full/10.1056/NEJM200105243442106
Braunholtz DA, Edwards SJL, Lilford RJ. Are randomized clinical trials good for us (in the short term)? Evidence for a “trial effect.” Journal of Clinical Epidemiology [Internet]. 2001 Feb 19 [cited 2026 July 21];54(3):217–24. Available from: https://www.sciencedirect.com/science/article/pii/s089543560000305x
Guo Y, Yang W, Lin C, Wu H, Li Z, Jiao R, et al. Placebo response on the weight change and its influencing factors in overweight or obesity with or without diabetes: a meta-analysis of 182 anti-obesity medications trials. Communications Medicine [Internet]. 2026 June 5 [cited 2026 July 21];. Available from: https://www.nature.com/articles/s43856-026-01659-7
Cizza G, Piaggi P, Rother KI, Csako G. Hawthorne Effect with Transient Behavioral and Biochemical Changes in a Randomized Controlled Sleep Extension Trial of Chronically Short-Sleeping Obese Adults: Implications for the Design and Interpretation of Clinical Studies. Penzel T, editor. PLoS ONE. 2014 Aug 20;9(8):e104176.
Li Y, Liu W, Yu G. Dancing in Shackles: The Double-Edged Sword Effect of Felt Accountability on Work Outcomes and Individual Wellbeing. Frontiers in Psychology. 2022 June 10;13.
Share with a friend. Rate, Review, and Subscribe to MedEvidence! Articles to be notified when new episodes are released.
Follow us on Social Media:
Facebook
Instagram
Twitter
LinkedIn
Tiktok
Youtube
For more great content, including discussions by physicians and clinical research experts, check out the MedEvidence! Podcast and MedEvidence.com
Thank you for listening!
In this week's episode, we look at the prevalence, pathophysiology, and progress towards a solution to urinary incontinence. We review what urinary incontinence is, look at the different types of incontinence, and explore what happens in the body that makes it tough to prevent leakage. Then we finish by looking at treatment options for those who suffer with the condition.
References:
Aoki Y, Brown HW, Brubaker L, Cornu JN, Daly JO, Cartwright R. Urinary incontinence in women. Nature reviews Disease primers. 2017 Jul 6;3(1):17042. https://doi.org/10.1038/nrdp.2017.42
Marieb EN, Hoehn K. Human anatomy & physiology. [11th Edition]. [Hoboken, New Jersey]: Pearson; [2019]. p. 1003-1007
Pan J, Liang E, Cai Q, Zhang D, Wang J, Feng Y, Yang X, Yang Y, Tian W, Quan C, Han R. Progress in studies on pathological changes and future treatment strategies of obesity-associated female stress urinary incontinence: a narrative review. Translational andrology and urology. 2021 Jan;10(1):494. https://tau.amegroups.org/article/view/60334/html
Long T, Cheng B, Zhang K. Abdominal obesity as assessed by anthropometric measures associates with urinary incontinence in females: findings from the National Health and Nutrition Examination Survey 2005–2018. BMC women's health. 2024 Apr 2;24(1):212. https://doi.org/10.1186/s12905-024-03059-2
Wing RR, Creasman JM, West DS, Richter HE, Myers D, Burgio KL, Franklin F, Gorin AA, Vittinghoff E, Macer J, Kusek JW. Improving urinary incontinence in overweight and obese women through modest weight loss. Obstetrics and gynecology. 2010 Aug;116(2 Pt 1):284. https://doi.org/10.1097/AOG.0b013e3181e8fb60
Subak LL, Wing R, West DS, Franklin F, Vittinghoff E, Creasman JM, Richter HE, Myers D, Burgio KL, Gorin AA, Macer J. Weight loss to treat urinary incontinence in overweight and obese women. New England Journal of Medicine. 2009 Jan 29;360(5):481-90. https://doi.org/10.1056/NEJMoa0806375
Share with a friend. Rate, Review, and Subscribe to MedEvidence! Articles to be notified when new episodes are released.
Follow us on Social Media:
Facebook
Instagram
Twitter
LinkedIn
Tiktok
Youtube
For more great content, including discussions by physicians and clinical research experts, check out the MedEvidence! Podcast and MedEvidence.com
Thank you for listening!
In this week's episode, we explore the world of hypogonadism, which typically manifests as low testosterone. We look at what testosterone is, the role it plays in the body, and what happens when testosterone is low. We then explore some common reasons for low testosterone and treatments that are available, as well as what's coming on the horizon.
References:
Anawalt BD, O’Connor KM, Grossmann M. Adult male hypogonadism: a review. JAMA. 2026 Jun 23;335(24):2146-59. https://doi.org/10.1001/jama.2026.8526
Carman W. The prevalence, incidence, and treatment rates of hypogonadism in men across geographies: a systematic literature review. Value in Health. 2013 Jan 1. https://doi.org/10.1016/j.jval.2013.03.315
Mulligan T, Frick MF, Zuraw QC, Stemhagen A, McWhirter C. Prevalence of hypogonadism in males aged at least 45 years: the HIM study. International journal of clinical practice. 2006 Jul;60(7):762-9. https://doi.org/10.1111/j.1742-1241.2006.00992.x
Davidiuk AJ, Broderick GA. Adult-onset hypogonadism: evaluation and role of testosterone replacement therapy. Translational andrology and urology. 2016 Dec;5(6):824. https://doi.org/10.21037/tau.2016.09.02
Bhasin S, Brito JP, Cunningham GR, Hayes FJ, Hodis HN, Matsumoto AM, Snyder PJ, Swerdloff RS, Wu FC, Yialamas MA. Testosterone therapy in men with hypogonadism: an endocrine society clinical practice guideline. The Journal of Clinical Endocrinology & Metabolism. 2018 May;103(5):1715-44. https://doi.org/10.1210/jc.2018-00229
Marieb EN, Hoehn K. Human anatomy & physiology. [11th Edition]. [Hoboken, New Jersey]: Pearson; [2019]. p. 601-641, 1060.
Jones TH, Dobs AS, Randeva H, Moore W, Parkin JM. Leflutrozole in male obesity-associated hypogonadotropic hypogonadism: Ph 2b double-blind randomised controlled trial. European journal of endocrinology. 2023 Sep;189(3):297-308. https://doi.org/10.1093/ejendo/lvad099
Wu F, Zitzmann M, Heiselman D, Donatucci C, Knorr J, Patel AB, Kinchen K. Demographic and clinical correlates of patient-reported improvement in sex drive, erectile function, and energy with testosterone solution 2%. The journal of sexual medicine. 2016 Aug;13(8):1212-9. https://doi.org/10.1016/j.jsxm.2016.05.010
Hussain A, Gilloteaux J. The human testes: estrogen and ageing outlooks. Translational Research in Anatomy. 2020 Sep 1;20:100073. https://doi.org/10.1016/j.tria.2020.100073
Gurayah AA, Dullea A, Weber A, Masterson JM, Khodamoradi K, Mohamed AI, Ramasamy R. Long vs short acting testosterone treatments: a look at the risks. Urology. 2023 Feb 1;172:5-12. https://doi.org/10.1016/j.urology.2022.11.016
Jones T, Dobs A, MacKinnon A, Parkin J. OR18-4 Beneficial Effect on Sperm Production of Leflutrozole in Men with Obesity-Associated Secondary Hypogonadotropic Hypogonadism: Results from a Phase II Study. Journal of the Endocrine Society. 2019 Apr;3(Supplement_1):OR18-4. https://doi.org/10.1210/js.2019-OR18-4
Share with a friend. Rate, Review, and Subscribe to MedEvidence! Articles to be notified when new episodes are released.
Follow us on Social Media:
Facebook
Instagram
Twitter
LinkedIn
Tiktok
Youtube
For more great content, including discussions by physicians and clinical research experts, check out the MedEvidence! Podcast and MedEvidence.com
Thank you for listening!
In this week's episode, we explore pancreatic cancer. This dangerous form of cancer has many things working against it: the pancreas is very near vital blood vessels, symptoms are vague, and there is no screening option available. As a result, most tumors aren't detected until surgical removal isn't an option, which leads to a high mortality rate. Listen to learn more about this devastating disease.
Share with a friend. Rate, Review, and Subscribe to MedEvidence! Articles to be notified when new episodes are released.
Follow us on Social Media:
Facebook
Instagram
Twitter
LinkedIn
Tiktok
Youtube
For more great content, including discussions by physicians and clinical research experts, check out the MedEvidence! Podcast and MedEvidence.com
Thank you for listening!
In this week's episode, we explore the difference between vaccines that are effective for live and those that must be renewed yearly. The difference is viruses that mutate frequently, like the flu, and those that don't, like measles. We explore the mechanism that makes some viruses better at evading our immune system and the tradeoff between high infection rate and high infection efficacy.
References:
Share with a friend. Rate, Review, and Subscribe to MedEvidence! Articles to be notified when new episodes are released.
Follow us on Social Media:
Facebook
Instagram
Twitter
LinkedIn
Tiktok
Youtube
For more great content, including discussions by physicians and clinical research experts, check out the MedEvidence! Podcast and MedEvidence.com
Thank you for listening!
In this week's episode, we explore a rare genetic disorder that results in excessive urination. X-Linked Congenital Nephrogenic Diabetes Insipidus (NDI) is a disease where sufferers produce excessive amounts of urine, causing dehydration, electrolyte imbalance, and other issues. We explore what causes this disease, why it results in so much extra urine production, and what treatments are available and coming down the pipeline.
References:
Share with a friend. Rate, Review, and Subscribe to MedEvidence! Articles to be notified when new episodes are released.
Follow us on Social Media:
Facebook
Instagram
Twitter
LinkedIn
Tiktok
Youtube
For more great content, including discussions by physicians and clinical research experts, check out the MedEvidence! Podcast and MedEvidence.com
Thank you for listening!
In this week's episode, written by guest author Daniel Benton, we examine the link between obesity and diabetes. We look at the underlying biological mechanisms that link the two conditions, why each can exacerbate the other, and what medications are available and on the horizon to help mange the linked conditions.
References:
Share with a friend. Rate, Review, and Subscribe to MedEvidence! Articles to be notified when new episodes are released.
Follow us on Social Media:
Facebook
Instagram
Twitter
LinkedIn
Tiktok
Youtube
For more great content, including discussions by physicians and clinical research experts, check out the MedEvidence! Podcast and MedEvidence.com
Thank you for listening!
In this week's episode, we explore what might be the oldest exercise: walking. We look at the effectiveness of walking in preventing heart disease and stroke, diabetes, and other conditions, explore why it's so effective, and look at how to get the most out of your walking routine; including when to walk and if walking faster really makes a difference.
References:
Share with a friend. Rate, Review, and Subscribe to MedEvidence! Articles to be notified when new episodes are released.
Follow us on Social Media:
Facebook
Instagram
Twitter
LinkedIn
Tiktok
Youtube
For more great content, including discussions by physicians and clinical research experts, check out the MedEvidence! Podcast and MedEvidence.com
Thank you for listening!
In this week's episode, we examine a little-known benefit of being in weight loss trials: the placebo effect. We look at data showing that most people lose weight in weight loss trials, even those who take no active medication, and explore how being on a placebo can improve markers of health. This helps underscore the importance of staying in clinical trials all the way to the end.
Share with a friend. Rate, Review, and Subscribe to MedEvidence! Articles to be notified when new episodes are released.
Follow us on Social Media:
Facebook
Instagram
Twitter
LinkedIn
Tiktok
Youtube
For more great content, including discussions by physicians and clinical research experts, check out the MedEvidence! Podcast and MedEvidence.com
Thank you for listening!
On this week's episode, we look at a disease commonly confused for normal "picky eating," Avoidant/Restrictive Food Intake Disorder. This disorder, which is driven by fear, disgust, sensory sensitivity, and/or a lack of appetite, leads to malnutrition and vitamin deficiency - especially in children. We look at what this disorder is and isn't, variants, some of the possible underlying causes, complications, and available therapies.
References:
Share with a friend. Rate, Review, and Subscribe to MedEvidence! Articles to be notified when new episodes are released.
Follow us on Social Media:
Facebook
Instagram
Twitter
LinkedIn
Tiktok
Youtube
For more great content, including discussions by physicians and clinical research experts, check out the MedEvidence! Podcast and MedEvidence.com
Thank you for listening!